These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 18389145

  • 1. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
    Conway CL, Walker I, Bell A, Roberts DJ, Brown SB, Vernon DI.
    Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protoporphyrin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy.
    Eshghi H, Sazgarnia A, Rahimizadeh M, Attaran N, Bakavoli M, Soudmand S.
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):304-12. PubMed ID: 23993857
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
    Frochot C, Di Stasio B, Vanderesse R, Belgy MJ, Dodeller M, Guillemin F, Viriot ML, Barberi-Heyob M.
    Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
    Sailer R, Strauss WS, Wagner M, Emmert H, Schneckenburger H.
    Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of protoporphyrin IX performance in aqueous solutions for photodynamic therapy.
    Homayoni H, Jiang K, Zou X, Hossu M, Rashidi LH, Chen W.
    Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):258-66. PubMed ID: 25636780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L, Wilson BC.
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [Abstract] [Full Text] [Related]

  • 12. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
    Sengar P, Juárez P, Verdugo-Meza A, Arellano DL, Jain A, Chauhan K, Hirata GA, Fournier PGJ.
    J Nanobiotechnology; 2018 Feb 27; 16(1):19. PubMed ID: 29482561
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
    Zhu W, Gao YH, Song CH, Lu ZB, Namulinda T, Han YP, Yan YJ, Wang LX, Chen ZL.
    Photochem Photobiol Sci; 2017 Nov 08; 16(11):1623-1630. PubMed ID: 28933502
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
    Huang Z, Wei G, Zeng Z, Huang Y, Huang L, Shen Y, Sun X, Xu C, Zhao C.
    Theranostics; 2019 Nov 08; 9(19):5542-5557. PubMed ID: 31534502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.